Chiral separation of verapamil and some of its metabolites by HPLC and CE.
HPLC and CE assays were developed for chiral separations of verapamil and its metabolites in serum samples. Three chiral HPLC columns (Chiralcel OJ, Chiralpak AD and Chiralcel OD-R) were tested in normal and reverse-phase modes. All HPLC analyses were performed with fluorescence detection at 276 and 310 nm. CE was realized using CM-beta-CD as a chiral selector for the enantiomeric analysis. The results of HPLC and CE studies were compared and the possibilities for the applications in therapeutic drug monitoring were discussed.
Brandsteterová
E
E
Department of Analytical Chemistry, Slovak Technical University, Bratislava, Slovakia. branstet@cvt.suba.sk
Endresz
G
G
Blaschke
G
G
D000688:Amylose / Q000737:chemistry; D001711:Biotransformation; D002121:Calcium Channel Blockers / Q000737:chemistry / Q000302:isolation & purification* / Q000493:pharmacokinetics; D002851:Chromatography, High Pressure Liquid; D003505:Cyclodextrins; D019075:Electrophoresis, Capillary; D006801:Humans; D007202:Indicators and Reagents; D013237:Stereoisomerism; D014700:Verapamil / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry / Q000302:isolation & purification* / Q000493:pharmacokinetics
D002121:Calcium Channel Blockers; D003505:Cyclodextrins; D007202:Indicators and Reagents; D000688:Amylose; C016904:norverapamil; D014700:Verapamil